State Bank of India sees sector's personal loan woes easing on tighter credit rules
State Bank of India (SBI) , the country's top lender by assets, expects the industry's concerns over retail borrowers ...
RBC Capital maintains $300 target on Alnylam stock, optimistic on access
RBC Capital Markets reiterated their positive stance on Alnylam Pharmaceuticals (NASDAQ:ALNY), maintaining an Outperform rating and a price target of $300.00. According to InvestingPro data, analyst ...
BuzzFeed’s New Plan: An AI-Powered Social Media Platform to Help “Spread Joy”
In an open letter, CEO Jonah Peretti calls out TikTok and Meta for prioritizing AI tech over content and says people miss the ...
Newmark Group (NMRK) Expected to Announce Quarterly Earnings on Friday
Newmark Group (NASDAQ:NMRK – Get Free Report) is expected to be announcing its earnings results before the market opens on Friday, February 14th. Analysts expect the company to announce earnings of $0 ...
in.investing.com on MSN17h
First Solar lifted to Buy at Mizuho on better sales outlook, competitive moat
Securities lifted its rating on First Solar (NASDAQ:FSLR) stock to Outperform from Neutral, in a move driven by an improved sales outlook post-2026 and a stronger competitive position in the US market ...
SailPoint sets sights on $12.57 billion valuation in US IPO
Initial public offerings in the U.S. are poised for a strong comeback after nearly three years of sluggish activity, with ...
Earnings call transcript: Royalty Pharma Q4 2024 misses EPS forecast
Royalty Pharma Plc (RPRX) reported its Q4 2024 earnings today, revealing earnings per share (EPS) of $0.3531, falling short of the forecasted $0.9849. The company also reported revenue of $594 million ...